Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HGI-001 in Transfusion-Dependent β-Thalassemia
NCT07721480Phase 2Not yet recruiting
- Sponsor
- Prince of Wales Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 2 trial of LentiHBBT87Q in beta thalassemia, sponsored by Prince of Wales Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
LentiHBBT87Q
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT07721480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721480.